Healthcare and pharmaceutical services provider Source BioScience is mooting acquisitions after turning a £181,000 interim loss into £62,000 pre-tax profits.
Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.